Announcements Trials
Browse Landscape

Phase

Phase 2 53Phase 1 31Phase 3 20Phase NA 17Phase 1/2 16Phase EARLY_PHASE1 5Phase 4 3Phase 2/3 3

Status

Active not recruiting 4Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 88CNS 88Genitourinary 62Lymphoid 59Breast 52Other hematologic neoplasm 42Other solid neoplasm 38Plasma cell 36Head & Neck 33Gynecologic 31Thoracic 30Dermatologic 24Sarcoma 21Endocrine 14Tumor-Agnostic 11NET 5Myeloid 5Other 4Classical hematology 4

Conditions

Neuroendocrine Tumors 4Recurrence 1Neuroendocrine Tumor Grade 2 1Adenoma, Islet Cell 1

Interventions

lutetium Lu 177 dotatate 1Single Photon Emission Computed Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 168Ga-pentixafor 168Ga-FAPI 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NET × 1 year × Clear all
NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT06148636 2025-11-04

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
24 enrolled
EndocrineNET

Adenoma, Islet Cell, Recurrence, Neuroendocrine Tumors

NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03335670 2025-07-14

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05111509 2025-07-14

A First-in-human Clinical Trial to Evaluate an Alpha-radiation Imaging Agent

University of Iowa

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
EndocrineNET

Neuroendocrine Tumor Grade 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡